相关实验视频
Updated: Apr 26, 2026

12:00
A Simplified Technique for Producing an Ischemic Wound Model
Published on: May 2, 2012
17.8K
西利马林在糖尿病伤口愈合中的保护作用:一篇综述
Hanghang Zhou1, Chengqing Ding2, Jianxiong Qiao1
1The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Medicine
|February 24, 2026
概括
西利玛林 (SM) 和其活性成分西利比宁 (SB) 通过减少炎症和氧化应激,对治疗糖尿病伤口充满希望. 需要进一步的临床研究来确认SM/SB对糖尿病伤口愈合的疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 皮肤病学 皮肤病学
背景情况:
- 糖尿病伤口是糖尿病 (DM) 的严重并发症,其特点是明显受损的愈合.
- 复杂的发病包括血管功能障碍,神经病变,高血糖,感染,炎症,氧化应激和免疫功能障碍.
- 目前糖尿病伤口的治疗方法有限,需要新的治疗策略.
研究的目的:
- 审查西利玛林 (SM) 和其活性成分西利比宁 (SB) 的治疗潜力,以增强糖尿病伤口愈合.
- 在糖尿病并发症的背景下,探索SM/SB有益影响的机制.
- 突出需要进一步研究和临床验证基于SM/SB的疗法.
主要方法:
- 关于与糖尿病和伤口愈合有关的西利玛林 (SM) 和西利比宁 (SB) 的同行评审研究的综合文献综述.
- 关于SM/SB.的抗炎,抗氧化,抗糖尿病,低血糖,神经保护和血管保护性质的证据综合.
- 探索SM/SB在促进糖尿病伤口关闭方面的潜在作用机制.
主要成果:
- 氨酸 (SM) 和氨酸 (SB) 具有显著的抗炎和抗氧化特性.
- SM/SB表现出抗糖尿病和降血糖作用,可能改善与伤口愈合相关的血糖控制.
- SM/SB的神经保护和血管/内皮保护作用可能有助于改善糖尿病患者的愈合结果.
结论:
- 西利玛林 (SM) 和西利比宁 (SB) 通过多种有益的机制显示出糖尿病伤口愈合的有前途的治疗潜力.
- 进一步的高质量的临床研究对于验证SM/SB在糖尿病伤口管理中的有效性至关重要.
- 生物材料的进步可以提高SM/SB的传递和有效性,促进新的伤口关闭疗法的临床转化.
相关概念视频
Diabetic Foot Ulcer
26
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
26
Diabetic Retinopathy
48
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
48

